Development and Evaluation of SARS-CoV-2 RNA Polymerase Inhibitors

Götte, Matthias | $675,000

Alberta University of Alberta 2020 CIHR Operating Grant

Coronaviruses (CoV) can cause severe human respiratory diseases, which is documented by three major outbreaks over the past 17 years: SARS-CoV in 2003, MERS-CoV in 2012, and currently SARS-CoV-2. In response to the current COVID‑19 outbreak caused by SARS-CoV-2, we propose to develop novel tools to discover, develop and evaluate inhibitors of the viral polymerase. The polymerase is an enzyme that is essentially required for the propagation of SARS-CoV-2, which makes it an attractive target for therapeutic intervention strategies.

With funding from the Government of Canada

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback